Idenix Pharmaceuticals to Present at the Canaccord Adams' Hepatitis C Conference

CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present a corporate overview at the upcoming Canaccord Adams' Hepatitis C Conference on Thursday, April 1, 2010 at 10:45 a.m. ET at The Peninsula Hotel, New York.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com.  Please log in approximately 5-10 minutes before the event to ensure a timely connection.  The archived replay will be available on the Idenix website for two weeks following the conference.  

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.

SOURCE Idenix Pharmaceuticals, Inc.